Clinical Trials in San Francisco

Showing 3261-3280 of 11,161 trials

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

NCT04588038

This phase I trial evaluates the side effects of NT-I7 in treating patients with squamous cell carcinoma of head and neck that has come back (recurrent) who are undergoing surgery. NT-I7 is an immunotherapy drug that works by helping the immune system fight tumor cells. The body produces T-cells which play an important role in body's immune response and its ability to recognize tumor cells. This immunotherapy drug may boost body's T-cells to help fight cancer and enhance body's response to cancer.

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+3 more

Hyunseok Kang, MD4 participantsStarted Mar 2021

San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

NCT02437318

To determine whether treatment with alpelisib plus fulvestrant prolonged progression-free survival (PFS) compared to fulvestrant and placebo in men and postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor-2 (HER2)-negative advanced breast cancer, who received prior treatment with an aromatase Inhibitor (AI) either as (neo)adjuvant or for advanced disease.

Breast Cancer

Novartis Pharmaceuticals572 participantsStarted Jul 2015

Chandler, Arizona, United States • Scottsdale, Arizona, United States • Fayetteville, Arkansas, United States +194 more locations

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

Find Trials by Condition in San Francisco

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

Comparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal Conditions

Improving Caregivers' Ability to Manage Life Stress

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Molecular Analysis of Breast Cancer

Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Foot and Ankle Post-operative Oedema Management Using Geko™

ATHN 7: Hemophilia Natural History Study

TK216 in Patients With Relapsed or Refractory Ewing Sarcoma

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men

Evaluation of the Phased Radio Frequency Ablation System

Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF

STOP Persistent AF

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors